MCID: HRT032
MIFTS: 74

Heart Disease

Categories: Cardiovascular diseases, Genetic diseases

Aliases & Classifications for Heart Disease

MalaCards integrated aliases for Heart Disease:

Name: Heart Disease 12 29 6 3 15
Congenital Heart Disease 12 29 55 6 15 73
Congenital Heart Defects 12 29 43 3 63
Heart Failure 55 6 43 63 73
Heart Diseases 55 43 44 73
Congenital Anomaly of Heart 12
Disease, Heart, Congenital 40
Congenital Heart Disorder 76
Heart Defects, Congenital 44
Heart Disease, Congenital 40
Congestive Heart Failure 73
Heart Defects Congenital 55
Congenital Heart Defect 12
Heart-Congenital Defect 12
Heart Malformation 12
Heart Defect 12

Classifications:



Summaries for Heart Disease

MedlinePlus : 43 If you're like most people, you think that heart disease is a problem for others. But heart disease is the number one killer in the U.S. It is also a major cause of disability. There are many different forms of heart disease. The most common cause of heart disease is narrowing or blockage of the coronary arteries, the blood vessels that supply blood to the heart itself. This is called coronary artery disease and happens slowly over time. It's the major reason people have heart attacks. Other kinds of heart problems may happen to the valves in the heart, or the heart may not pump well and cause heart failure. Some people are born with heart disease. You can help reduce your risk of heart disease by taking steps to control factors that put you at greater risk: Control your blood pressure Lower your cholesterol Don't smoke Get enough exercise NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Heart Disease, also known as congenital heart disease, is related to dilated cardiomyopathy and congestive heart failure, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Heart Disease is GATA4 (GATA Binding Protein 4), and among its related pathways/superpathways are Cardiac conduction and Human Embryonic Stem Cell Pluripotency. The drugs Menthol and Ranolazine have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and endothelial, and related phenotype is muscle.

CDC : 3 In the United States, the most common type of heart disease is coronary artery disease (CAD), which can lead to heart attack. You can greatly reduce your risk for CAD through lifestyle changes and, in some cases, medication. Learn more about heart disease.

Disease Ontology : 12 A cardiovascular system disease that involves the heart.

PubMed Health : 63 About congenital heart defects: Congenital (kon-JEN-ih-tal) heart defects are problems with the heart's structure that are present at birth. These defects can involve:

Wikipedia : 76 A congenital heart defect (CHD), also known as a congenital heart anomaly or congenital heart disease,... more...

Related Diseases for Heart Disease

Diseases in the Heart Disease family:

Congenital Heart Defects, Multiple Types, 6 Congenital Heart Defects, Multiple Types, 3
Congenital Heart Defects, Multiple Types, 2 Congenital Heart Defects, Multiple Types, 4
Congenital Heart Defects, Multiple Types, 5

Diseases related to Heart Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 912)
# Related Disease Score Top Affiliating Genes
1 dilated cardiomyopathy 33.7 ADRB1 GATA4 MYH6 NKX2-5 NPPA NPPB
2 congestive heart failure 33.7 ADRB1 HOTAIR MYH6 NPPA NPPB
3 coronary artery anomaly 33.7 ADRB1 H19 NPPA NPPB
4 hypoplastic left heart syndrome 33.4 MYH6 NKX2-5 NPPA NPPB
5 atrial fibrillation 32.7 ADRB1 NPPA NPPB RYR2
6 atrioventricular block 32.3 GATA4 NKX2-5 NPPB
7 atrial standstill 1 32.3 ADRB1 MIR320A MYH6 NPPB
8 acute myocardial infarction 32.1 ADRB1 MHRT NPPA NPPB
9 myocardial infarction 32.0 ADRB1 GATA4 MIR21 MIR210 MT-LIPCAR NPPA
10 left ventricular noncompaction 32.0 MHRT MYH6 NKX2-5 RYR2
11 tetralogy of fallot 31.9 GATA4 NKX2-5 NPPA NPPB
12 ventricular septal defect 31.7 GATA4 NKX2-5 NPPB
13 atrial heart septal defect 31.7 GATA4 MYH6 NKX2-5
14 ebstein anomaly 31.5 GATA4 NKX2-5 NPPB
15 patent foramen ovale 31.2 GATA4 MYH6 NKX2-5
16 central sleep apnea 31.2 NPPA NPPB
17 dermatomyositis 29.5 MIR21 MIR210
18 thyroid cancer, nonmedullary, 1 29.0 H19 HOTAIR MIR21
19 ovarian cancer 28.4 ABL1 BACE1-AS H19 HOTAIR MIR21 MIR210
20 short stature, developmental delay, and congenital heart defects 12.4
21 coronary heart disease 1 12.4
22 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 12.3
23 multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defects 12.3
24 hypertensive heart disease 12.3
25 rheumatic heart disease 12.2
26 ischemic heart disease 12.2
27 critical congenital heart disease 12.1
28 coronary heart disease 5 12.1
29 coronary heart disease 7 12.1
30 coronary heart disease 6 12.1
31 testicular anomalies with or without congenital heart disease 12.1
32 kyphoscoliotic heart disease 12.1
33 coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies syndrome 12.0
34 chronic pulmonary heart disease 12.0
35 polyvalvular heart disease syndrome 11.9
36 coronary heart disease 2 11.9
37 coronary heart disease 4 11.9
38 craniostenosis, sagittal, with congenital heart disease, mental deficiency, and mandibular ankylosis 11.8
39 coronary heart disease 3 11.8
40 coronary heart disease 8 11.8
41 coronary heart disease 9 11.8
42 acute pulmonary heart disease 11.8
43 hirschsprung disease polydactyly heart disease 11.8
44 microcephaly, congenital heart disease, unilateral renal agenesis, and hyposegmented lungs 11.8
45 craniofacial abnormalities, cataracts, congenital heart disease, sacral neural tube defects, and growth and developmental retardation 11.8
46 cleft lip/palate with characteristic facies, intestinal malrotation, and lethal congenital heart disease 11.8
47 cleft palate heart disease polydactyly absent tibia 11.8
48 congenital heart disease ptosis hypodontia craniostosis 11.8
49 congenital heart disease radio ulnar synostosis mental retardation 11.8
50 short limbs abnormal face congenital heart disease 11.8

Comorbidity relations with Heart Disease via Phenotypic Disease Network (PDN): (show top 50) (show all 321)


3-Hydroxyacyl-Coa Dehydrogenase Deficiency Accessory Nerve Disease
Acquired Polycythemia Acquired Thrombocytopenia
Active Peptic Ulcer Disease Acute Anterolateral Myocardial Infarction
Acute Apical Periodontitis Acute Conjunctivitis
Acute Cor Pulmonale Acute Cystitis
Acute Inferolateral Myocardial Infarction Acute Kidney Failure
Acute Maxillary Sinusitis Acute Myocardial Infarction
Acute Myocarditis Acute Pancreatitis
Acute Vascular Insufficiency of Intestine Adjustment Disorder
Age-Related Hearing Loss Alcoholic Cardiomyopathy
Alcoholic Liver Cirrhosis Allergic Urticaria
Alzheimer Disease Amyloidosis
Anemia, Autoimmune Hemolytic Anthracosis
Anxiety Aortic Aneurysm
Aortic Atherosclerosis Aortic Valve Disease 1
Aortic Valve Disease 2 Aortic Valve Insufficiency
Asbestosis Aspergillosis
Asthma Atrial Standstill 1
Atrioventricular Block Atrophic Gastritis
Bacteremia 2 Balanoposthitis
Basilar Artery Insufficiency Benign Essential Hypertension
Benign Hypertensive Renal Disease Benign Renovascular Hypertension
Bleeding Disorder, Platelet-Type, 11 Blepharitis
Blepharoconjunctivitis Bronchiectasis
Bronchitis Bronchopneumonia

Graphical network of the top 20 diseases related to Heart Disease:



Diseases related to Heart Disease

Symptoms & Phenotypes for Heart Disease

UMLS symptoms related to Heart Disease:


angina pectoris, chest pain, edema, tremor, equilibration disorder, syncope

MGI Mouse Phenotypes related to Heart Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 9.17 ABL1 ADRB1 GATA4 MYH6 NKX2-5 NPPA

Drugs & Therapeutics for Heart Disease

PubMedHealth treatment related to Heart Disease: 63

Although many children who have congenital heart defects don't need treatment, some do. Doctors repair congenital heart defects with catheter procedures or surgery.Sometimes doctors combine catheter and surgical procedures to repair complex heart defects, which may involve several kinds of defects.The treatment your child receives depends on the type and severity of his or her heart defect. Other factors include your child's age, size, and general health.Some children who have complex congenital heart defects may need several catheter or surgical procedures over a period of years, or they may need to take medicines for years.

Drugs for Heart Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1175)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 2216-51-5 16666
2
Ranolazine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 142387-99-3, 95635-55-5 56959
3
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-78-2 2244
4
Cilostazol Approved, Investigational Phase 4,Not Applicable 73963-72-1 2754
5
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 120202-66-6, 113665-84-2 60606
6
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 159351-69-6 6442177
7
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
8
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53123-88-9 5284616 6436030 46835353
9
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 55142-85-3 5472
10
Fluvastatin Approved Phase 4,Phase 3,Phase 2 93957-54-1 1548972
11
Carvedilol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 72956-09-3 2585
12
Clonidine Approved Phase 4,Not Applicable 4205-90-7 2803
13
Dobutamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 34368-04-2 36811
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
15
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 113775-47-6 68602 5311068
16
Etomidate Approved Phase 4,Phase 2 33125-97-2 36339 667484
17
Hydromorphone Approved, Illicit Phase 4,Phase 2 466-99-9 5284570
18
Ropivacaine Approved Phase 4,Phase 2,Not Applicable 84057-95-4 71273 175805
19
Sevoflurane Approved, Vet_approved Phase 4,Phase 2,Not Applicable,Early Phase 1 28523-86-6 5206
20
Sufentanil Approved, Investigational Phase 4,Phase 2,Not Applicable 56030-54-7 41693
21
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 33069-62-4 36314
22
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 274693-27-5 9871419
23
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 9005-49-6 772 46507594
24
Nicorandil Approved, Investigational Phase 4,Not Applicable 65141-46-0 47528
25
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
26
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
27
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
28
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 137862-53-4 60846
29
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 111025-46-8 4829
30
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6 23994
31
Verapamil Approved Phase 4,Phase 3,Phase 2,Not Applicable 52-53-9 2520
32
Amiodarone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1951-25-3 2157
33
Chromium Approved Phase 4,Phase 3,Not Applicable 7440-47-3 27668
34
Esomeprazole Approved, Investigational Phase 4,Phase 2 161796-78-7, 119141-88-7 4594 9579578
35
Pantoprazole Approved Phase 4,Phase 3,Phase 1 102625-70-7 4679
36
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
37
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-28-2 5757
38 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 979-32-8
39
Medroxyprogesterone acetate Approved, Investigational Phase 4,Phase 2,Phase 3 71-58-9
40
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 28014-46-2
41
Progesterone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 57-83-0 5994
42
Exenatide Approved, Investigational Phase 4,Phase 3,Not Applicable 141758-74-9 15991534
43
Cyproterone Acetate Approved, Investigational Phase 4 427-51-0
44
Ethinyl Estradiol Approved Phase 4,Phase 1,Not Applicable 57-63-6 5991
45
Citalopram Approved Phase 4,Not Applicable 59729-33-8 2771
46
Ezetimibe Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 163222-33-1 150311
47
Irbesartan Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 138402-11-6 3749
48
Ramipril Approved Phase 4,Phase 3,Phase 2,Not Applicable 87333-19-5 5362129
49
Amlodipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 88150-42-9 2162
50
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 58-93-5 3639

Interventional clinical trials:

(show top 50) (show all 10003)
# Name Status NCT ID Phase Drugs
1 Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist Unknown status NCT00668824 Phase 4 Vasovist
2 Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function Unknown status NCT01825759 Phase 4 danshen dripping pill
3 Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease-2 Unknown status NCT01664858 Phase 4
4 The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients Unknown status NCT02850627 Phase 4 Tongguan capsule;placebo capsule
5 Ranolazine for Improving Symptoms of Palpitations Unknown status NCT01495520 Phase 4 Ranolazine;Placebo
6 Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection Unknown status NCT02694848 Phase 4 Salvianolate injection;Aspirin
7 Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen Unknown status NCT01267734 Phase 4 Triple anti-platelet therapy (TAT);Double-dose clopidogrel anti-platelet therapy (DDAT)
8 Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease Unknown status NCT00917527 Phase 4 Atorvastatin
9 Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Unknown status NCT01768585 Phase 4 Ivabradine;Placebo
10 Fluvastatin AmelIorates aTHerosclerosis Study Unknown status NCT01681199 Phase 4 Fluvastatin extended release tablet
11 Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Unknown status NCT01382277 Phase 4 Rosuvastatin
12 Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography Unknown status NCT00850486 Phase 4
13 Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery Unknown status NCT01457586 Phase 4
14 Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol Unknown status NCT01425164 Phase 4 Ivabradine;Carvedilol
15 EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine) Unknown status NCT00335582 Phase 4 clonidine hydrochloride
16 Study of Effects of Sildenafil on Patients With Fontan Heart Circulation Unknown status NCT01815502 Phase 4 Dobutamine
17 Studies of Application of Combined General Anesthesia and Bilateral TPVB in OPCABG Unknown status NCT02727712 Phase 4 Anesthesia drugs during the surgery
18 Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES) Unknown status NCT01942044 Phase 4
19 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Unknown status NCT01021930 Phase 4
20 Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing Unknown status NCT01456364 Phase 4 Ticagrelor;Prasugrel
21 Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography Unknown status NCT01260558 Phase 4
22 Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography Unknown status NCT01230723 Phase 4
23 Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents Unknown status NCT01068106 Phase 4
24 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
25 Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease Unknown status NCT00188188 Phase 4 quinipril
26 Enteral Nutrition After Cardiovascular Surgery Unknown status NCT01432769 Phase 4
27 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4 acarbose
28 Metformin in Postmenopausal Women With Metabolic Syndrome Unknown status NCT01342744 Phase 4 Metformin;Placebo
29 Effect of Rosuvastatin Therapy on HDL2 Level Unknown status NCT02593487 Phase 4 Rosuvastatin 10mg/d group;Rosuvastatin 20mg/d group
30 The ABC Trial Does All-Blood Cardioplegia Prevent Blood Transfusion in Cardiac Surgery? A Single Centre Pilot Study Unknown status NCT01623193 Phase 4
31 Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction Unknown status NCT00888758 Phase 4
32 Revascularization in Heart Failure Trial – REHEAT 2 Unknown status NCT00388245 Phase 4
33 Effect of Ranolazine on Valvular Disease in Patients With Pacemakers Unknown status NCT01979965 Phase 4 Ranolazine (Active drug);Placebo
34 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
35 Patent Versus Generic Clopidogrel in Acute Coronary Syndrome Unknown status NCT02628587 Phase 4 Generic clopidogrel;Patent clopidogrel
36 Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients Unknown status NCT01503671 Phase 4 Atorvastatin
37 The Low HDL On Six Weeks Statin Therapy (LOW) Study Unknown status NCT00238004 Phase 4 Nicotinic acid
38 Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Unknown status NCT00584350 Phase 4
39 Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients Unknown status NCT00155350 Phase 4 pioglitazone
40 Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy Unknown status NCT00348530 Phase 4 Verapamil
41 Therapy With Verapamil or Carvedilol in Chronic Heart Failure Unknown status NCT00374465 Phase 4 Verapamil;Carvedilol
42 Rosuvastatin Effect on Telomere-telomerase System in ACS Unknown status NCT02299245 Phase 4 rosuvastatin
43 Does Sildenafil Protect Against Pulmonary Related Complications Following Cardiopulmonary Bypass? Unknown status NCT00350441 Phase 4 Sildenafil Citrate
44 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4 Amiodarone;Pharmacotherapy to slow and control ventricular rate
45 Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII Unknown status NCT01918150 Phase 4
46 Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay Unknown status NCT01023360 Phase 4 Clopidogrel and proton pump inhibitors
47 Multi-centre Clinical Trial on Hormone Replacement Treatment in China Unknown status NCT01698164 Phase 4 estradiol plus MPA;Ximingting Tablet;estradiol plus progesterone
48 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4 Reduced duration (6 months) DAPT
49 Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function Unknown status NCT02584075 Phase 4 Byetta (Exenatide);Glucophage ( Metformin Hydrochloride)
50 The Randomized Controlled Clinical Trial of Kushen Injection Unknown status NCT02346318 Phase 4 Compound Kushen Injection

Search NIH Clinical Center for Heart Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: heart diseases

Genetic Tests for Heart Disease

Genetic tests related to Heart Disease:

# Genetic test Affiliating Genes
1 Congenital Heart Disease 29
2 Congenital Heart Defects 29
3 Heart Disease 29

Anatomical Context for Heart Disease

MalaCards organs/tissues related to Heart Disease:

41
Heart, Testes, Endothelial, Kidney, Lung, Brain, Bone

Publications for Heart Disease

Articles related to Heart Disease:

(show top 50) (show all 5863)
# Title Authors Year
1
Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease. ( 29343820 )
2018
2
Coagulation Factors in Ischemic Heart Disease: Answers From a Mendelian Randomization Study Inspire Further Questions. ( 29874185 )
2018
3
Management of radiation-induced valvular heart disease due to Hodgkin's Lymphoma in the modern era. ( 29131805 )
2018
4
Survival and Associated Risk Factors for Mortality Among Infants with Critical Congenital Heart Disease in a Developing Country. ( 29756159 )
2018
5
Perioperative neonatal brain injury is associated with worse school-age neurodevelopment in children with critical congenital heart disease. ( 29572821 )
2018
6
The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review. ( 29897915 )
2018
7
A Modified Algorithm for Critical Congenital Heart Disease Screening Using Pulse Oximetry. ( 29691284 )
2018
8
Human cytomegalovirus infection and coronary heart disease: a systematic review. ( 29409508 )
2018
9
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited. ( 29948832 )
2018
10
Validation of acute kidney injury according to the modified KDIGO criteria in infants after cardiac surgery for congenital heart disease. ( 29451341 )
2018
11
Out-of-Hospital Cardiac Arrest in the Presence of Ischemic Heart Disease: What Is the Long-term Arrhythmic Risk After Revascularization? ( 29958725 )
2018
12
Diagnosis and treatment of postoperative intestinal perforation in infants and young children with congenital heart disease: A report of three cases. ( 29731834 )
2018
13
Outcomes for patients with rheumatic heart disease after cardiac surgery followed at rural district hospitals in Rwanda. ( 29678896 )
2018
14
A Hybrid Model for Advanced Structural Heart Disease Training Programs: The Attending-Fellow-in-Training Model. ( 29447743 )
2018
15
Global Burden of Rheumatic Heart Disease. ( 29303541 )
2018
16
Pediatric Coronary Artery Bypass Surgery for Congenital Heart Disease (Commentary). ( 29964019 )
2018
17
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study. ( 29653582 )
2018
18
Coagulation Factors and the Risk of Ischemic Heart Disease: A Mendelian Randomization Study. ( 29874180 )
2018
19
Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease. ( 29850230 )
2018
20
Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments. ( 29396305 )
2018
21
The association of plasma high-sensitivity C-reactive protein level with rheumatic heart disease: The possible role of inflammation. ( 29961448 )
2018
22
Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series. ( 29908036 )
2018
23
Mitral stenosis due to rheumatic heart disease - A rare cause of massive hemoptysis. ( 29977754 )
2018
24
Global Burden of Rheumatic Heart Disease. ( 29303543 )
2018
25
Association Between the Interferon Gamma 874 T/A Polymorphism and the Severity of Valvular Damage in Patients with Rheumatic Heart Disease. ( 29332266 )
2018
26
Task sharing to improve the prevention, diagnosis and management of rheumatic heart disease: a systematic review protocol. ( 29444786 )
2018
27
Update in Women's Heart Disease: Prevention and Screening. ( 29446715 )
2018
28
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis. ( 29439019 )
2018
29
An essential role for Wnt/I^-catenin signaling in mediating hypertensive heart disease. ( 29895976 )
2018
30
Influence of cytokine gene polymorphism on the risk of rheumatic heart disease - A meta-analysis. ( 29317215 )
2018
31
The association of neck circumference with incident congestive heart failure and coronary heart disease mortality in a community-based population with or without sleep-disordered breathing. ( 29855261 )
2018
32
College students with congenital heart disease: A critical time for transition. ( 29452064 )
2018
33
Prevention and control of rheumatic heart disease: Overcoming core challenges in resource-poor environments. ( 29440834 )
2018
34
Association between unplanned readmission to a different hospital and all-cause mortality among older patients with ischemic heart disease: A nationwide claim study. ( 29371060 )
2018
35
Cerebral Protection During Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Heart Disease. ( 29960991 )
2018
36
Physicians Addicted to Prescribing Aspirin-a Disorder Of Cardiologists (PAPA-DOC) Syndrome: The Headache of Nonevidence-Based Medicine for Ischemic Heart Disease? ( 29413373 )
2018
37
The impact of the maternal-foetal environment on outcomes of surgery for congenital heart disease in neonates. ( 29447332 )
2018
38
Trends in Deaths from Rheumatic Heart Disease in the Eastern Mediterranean Region: Burden and Challenges. ( 29848951 )
2018
39
Global Burden of Rheumatic Heart Disease. ( 29298147 )
2018
40
Different Nuss procedures and risk management for pectus excavatum after surgery for congenital heart disease. ( 29716732 )
2018
41
Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease). ( 29305400 )
2018
42
Three-dimensional echocardiography: a further step in the evaluation of hypertensive heart disease. ( 29952849 )
2018
43
Fine particulate matter and incident coronary heart disease in the REGARDS cohort. ( 29447790 )
2018
44
A study on the relationship between plasma selenium concentration and erythrocyte deformability in rat models of coronary heart disease. ( 29442482 )
2018
45
Utility of Fluid Assessment Based on the Intrathoracic Impedance Monitoring in a Peripartum Woman with Heart Disease. ( 29445057 )
2018
46
Determinants of Increased Aortic Diameters in Young Normotensive Patients With Turner Syndrome Without Structural Heart Disease. ( 29392348 )
2018
47
Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking. ( 29970414 )
2018
48
Quadruple valve replacement in a patient with severe rheumatic heart disease. ( 29674478 )
2018
49
Loss-Framed Financial Incentives and Personalized Goal-Setting to Increase Physical Activity Among Ischemic Heart Disease Patients Using Wearable Devices: The ACTIVE REWARD Randomized Trial. ( 29899015 )
2018
50
Prevalence of rheumatic heart disease in Zambian school children. ( 29969998 )
2018